Abstract
VIP and PACAP are two prominent neuropeptides which share two common G protein-coupled receptors VPAC1 and VPAC2 while PACAP has an additional specific receptor PAC1. This paper reviews the present knowledge regarding three aspects of VPAC receptors including: (i). receptor specificity towards natural VIP-related peptides and pharmacology of synthetic agonists or antagonists; (ii). receptor signaling; (iii). molecular basis of ligand-receptor interaction as determined by site-directed mutagenesis, construction of receptor chimeras and structural modeling.
MeSH terms
-
Amino Acid Sequence
-
Animals
-
Humans
-
Ligands
-
Models, Molecular
-
Neuropeptides / physiology*
-
Pituitary Adenylate Cyclase-Activating Polypeptide
-
Protein Conformation
-
Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide
-
Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I
-
Receptors, Pituitary Hormone / physiology*
-
Receptors, Vasoactive Intestinal Peptide / chemistry
-
Receptors, Vasoactive Intestinal Peptide / physiology*
-
Receptors, Vasoactive Intestinal Peptide, Type II
-
Receptors, Vasoactive Intestinal Polypeptide, Type I
-
Substrate Specificity
-
Vasoactive Intestinal Peptide / chemistry
-
Vasoactive Intestinal Peptide / metabolism*
Substances
-
ADCYAP1 protein, human
-
ADCYAP1R1 protein, human
-
Ligands
-
Neuropeptides
-
Pituitary Adenylate Cyclase-Activating Polypeptide
-
Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide
-
Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I
-
Receptors, Pituitary Hormone
-
Receptors, Vasoactive Intestinal Peptide
-
Receptors, Vasoactive Intestinal Peptide, Type II
-
Receptors, Vasoactive Intestinal Polypeptide, Type I
-
VIPR1 protein, human
-
VIPR2 protein, human
-
Vasoactive Intestinal Peptide